John Chapin, M.D.




  1. Maeda Y, Solanky M, Menonna J, Chapin J, Li WP, Dowling P. Platelet-Derived Growth Factor-alpha Receptor-positive Oligodendroglia Are Frequent in Multiple Sclerosis Lesions. Ann Neurol 2001; 49(6):776-85. 


  1. Li W, Maeda Y, Ming X, Cook S, Chapin J, Husar W, Dowling P. Apoptotic death following Fas activation in human oligodendrocyte hybrid cultures.
    J Neurosci Res 2002;69(2):189-96.


  1. Chapin J, Weksler B, Magro C, and Laurence J. Eculizumab in the Treatment of Refractory Idiopathic Thrombotic Thrombocytopenic Purpura. Br J Haematol 2012; 157(6):772-4.


  1. Chapin J, Cardi D, Gibb C, Laurence J. Combined Factor V-Factor VIII deficiency: A report of a case, genetic analysis, and response to DDAVP. Clin Adv Hem Oncol 2012; 10 (7): 472-6.


  1. Chapin J, Eyler S, Smith R, Tsai HM, Laurence J. Complement factor H mutations are present in ADAMTS13 deficient, ticlopidine-associated TTP. Blood 2013. In Press.


  1. Chapin J, Hojjati H, Schneider B. Woman with diffuse joint pains. Consultant. In Press.


  1. Tsai E, Zhou W, Chapin J, Laurence J, Tsai HM. Use of eculizumab in the treatment of a case of refractory, ADAMTS13 deficient thrombotic  thrombocytopenic purpura: additional data and clinical follow-up. Br J Haematol 2013. In Press.


Back to topBack To Top